In vivo xenograft mouse models demonstrated that KGM reverses 5-FU resistance in HCC tumors by inhibiting TLR4 to increase ER stress and activate PERK/ATF/CHOP signaling. This evidence concerns the gene TLR4 and hepatocellular carcinoma.